Stoke Therapeutics, Inc. logo

Stoke Therapeutics, Inc.

STOK

NASDAQHealthcareBiotechnology

Previous close

$32.29

+$0.89 · +2.83%

Aug 21, 4:00 PM ET

STOK company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

52

Fair Value

Momentum

46

Neutral

Sentiment

34

Bearish

Risk resilience

57

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Industry
Biotechnology
Sector
Healthcare
Headquarters
US

Market position

Day range

Current $32.29

52-week range

Current $32.29

Open
$31.665
Previous close
$31.40
Volume
1.27M
Market cap
2.08B USD
50-day average
$30.8992
+4.50% above average
200-day average
$31.6132
+2.14% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
1.8B USD
P/E (TTM)
-9.61×
P/B (TTM)
6.17×
P/S (TTM)
75.52×
EV / EBITDA
-351.59×
Earnings yield
-0.37%
Free cash flow yield
2.39%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
84.67%
Operating margin
-809.69%
Net margin
-753.60%
Return on equity
-1.95%
Return on assets
-1.65%
Return on invested capital
-5.66%

Financial health

Debt / equity
0.01×
Current ratio
5.28×

Earnings

EPS beat rate
73%
8 beats, 3 misses, 0 met estimates
Average EPS surprise
+61.80%
11 comparable reports
Latest EPS result
-0.93
Estimate -0.8 · Miss by 16.98%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates2.131.02-0.09-1.2Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Mar 18, 2025: actual -0.18, estimate -0.51, surprise +64.71%, Beat. Q2 2025, reported May 13, 2025: actual 1.9, estimate -0.37, surprise +613.51%, Beat. Q3 2025, reported Aug 12, 2025: actual -0.4, estimate -0.57, surprise +29.82%, Beat. Q4 2025, reported Nov 4, 2025: actual -0.65, estimate -0.54, surprise -20.37%, Miss. Q1 2026, reported Mar 16, 2026: actual -0.97, estimate -0.75, surprise -29.33%, Miss. Q2 2026, reported May 7, 2026: actual -0.79, estimate -0.8, surprise +1.25%, Beat. Q3 2026, reported Aug 3, 2026: actual -0.93, estimate -0.795, surprise -16.98%, Miss. Q4 2026, reported Nov 3, 2026: actual —, estimate -0.87, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates171.14M114.49M57.84M1.19MQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26MissQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Mar 18, 2025: actual 22.61M USD, estimate 3.86M USD, surprise +485.85%, Beat. Q2 2025, reported May 13, 2025: actual 158.57M USD, estimate 31.51M USD, surprise +403.19%, Beat. Q3 2025, reported Aug 12, 2025: actual 13.82M USD, estimate 5.36M USD, surprise +157.99%, Beat. Q4 2025, reported Nov 4, 2025: actual 10.63M USD, estimate 4.56M USD, surprise +133.39%, Beat. Q1 2026, reported Mar 16, 2026: actual 1.4M USD, estimate 5.83M USD, surprise -75.97%, Miss. Q2 2026, reported May 7, 2026: actual 6.23M USD, estimate 6.48M USD, surprise -3.92%, Miss. Q3 2026, reported Aug 3, 2026: actual 9.33M USD, estimate 4.89M USD, surprise +90.70%, Beat. Q4 2026, reported Nov 3, 2026: actual —, estimate 8.21M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

16 ratings
Strong buy00%
Buy1381%
Hold319%
Sell00%
Strong sell00%

STOK news

STOK peers

ETFs holding STOK

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research STOK

research.disclaimer